CDC panel recommends Moderna, J&J vaccine boosters for certain adults
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today voted unanimously to recommend a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series, in the same risk groups for whom CDC recommended a Pfizer booster dose. These risk groups include people age 65 and older and residents in long-term care settings; people aged 50-64 with underlying medical conditions; people aged 18-49 with underlying medical conditions, based on their individual benefit and risks; and people aged 18-64 who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting, based on their individual benefits and risks.
In addition, ACIP voted unanimously to recommend a single COVID-19 vaccine booster dose for adults at least two months after receiving an initial Johnson & Johnson COVID-19 vaccine dose.
CDC’s director next will consider the ACIP recommendations.